Company / Revenue per Share
Royalty Pharma plc Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$3.94
FY2025
5-year range
$3.94 / $5.68
FY2021-FY2025
Trend
-23.7%
vs FY2024
Sector context
#68 of 154
Health Care
What the data says
At $3.94, Royalty Pharma plc's revenue per share ranks #68 of 154 in the Health Care sector. Declined from $5.68 to $3.94 over the past 2 years.
Based on SEC 10-K filings.
3.94 in FY2025 with a 5-year CAGR of -3.8%.
Declined from $5.68 to $3.94 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -11.3%
- 5-Year CAGR
- -3.8%
- 10-Year CAGR
- -
Sector benchmark
#68 of 154 in Health CareTop 44% of 154This company $3.94 Sector average $10.35
▼
-61.9% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 23.7% year-over-year.
- Ranks #68 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.94 | -23.7% |
| FY2024 | $5.17 | -8.9% |
| FY2023 | $5.68 | +0.4% |
| FY2022 | $5.65 | +17.0% |
| FY2021 | $4.83 | +1.1% |
| FY2020 | $4.78 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026